Primaa, a French AI healthtech startup transforming digital pathology and cancer diagnostics, has raised €7 million in an extended funding round to accelerate product development and international expansion.
French DeepTech scale-up Dracula Technologies, a leader in ambient light energy harvesting, has extended its Series A round to €30 million to accelerate the industrialization and global rollout of its battery-free IoT solutions.
Franco-Italian startup Volta has raised €5 million in fresh funding to accelerate its mission to modernize B2B commerce through AI automation. The round was led by RTP Global, with participation from Pascal Houillon (former CEO of Cegid and Sage), and existing investors Emblem, Robin Capital, and Founders Future.
Clinical-stage biotech Exeliom Biosciences has secured an additional €2.85 million in Series A funding, bringing its total Series A round to €11.85 million.
Trusttech startup Certificall has raised €1 million in seed funding to accelerate its European expansion and strengthen its certified visual evidence technology for insurers, brokers, and industrial clients.
Biopharma startup Adcytherix, a developer of next-generation antibody-drug conjugates (ADCs), has raised €105 million in a record-breaking Series A round to accelerate the development of its lead therapeutic candidate targeting hard-to-treat cancers.
Biotech innovator EVerZom has raised €10 million to advance the development of its exosome-based regenerative medicine therapies, aiming to bring next-generation treatments to patients and strengthen its position as a European leader in tissue repair and organ regeneration.
Phagos, a Paris-based biotechnology company developing AI-driven bacteriophage therapies as sustainable alternatives to antibiotics, has raised €25 million in Series A funding.
